Enveric Biosciences Inc
Sector: Manufacturing
Industry: Semiconductor and Related Device Manufacturing
1.81
-0.01
(-0.549%)
Volume:
0
52 week range:
1.57 - 20
Market Cap:
3.762M
Company Description:
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy.